Abstract
We report the case of a 53-year-old Caucasian woman who developed nodal melanoma metastasis under infliximab therapy 2 years after the removal of a nevoid melanoma, which was initially misdiagnosed as a benign compound nevus. This case illustrates the potential link between tumor necrosis factor (TNF)- inhibition and the reactivation of latent melanoma. Furthermore, this case highlights the need for a complete skin examination before using anti-TNF- therapy to rule out atypical malignant lesions or melanomas that can easily be missed because of presentations such as nevoid melanoma. © 2013 S. Karger AG, Basel.
Author supplied keywords
Cite
CITATION STYLE
Safa, G., Fromentoux, S., Darrieux, L., Hogenhuis, J. A., & Tisseau, L. (2013). Nodal melanoma metastasis under infliximab therapy in a patient with nevoid melanoma first misdiagnosed as benign nevus: A potentially dangerous diagnostic pitfall in the era of biologic therapies. Case Reports in Dermatology, 5(3), 290–294. https://doi.org/10.1159/000355670
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.